Impact of 30 Day Readmission After Left Ventricular Assist Device Implantation

ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs
Saurabh GuptaRanjit John

Abstract

Early readmission (within 30 days) after left ventricular assist device (LVAD) implantation might be a marker for increased mortality. We retrospectively reviewed the records of 277 adults who underwent continuous-flow LVAD implantation from 2005 through 2015 at our institution. The baseline characteristics of patients who were (versus were not) readmitted within 30 days after LVAD implantation were compared. To assess the impact of 30 day readmission on long-term survival, we used multivariate Cox regression. We also compared the cardiac transplant rate between the two groups. Of the 277 patients, 217 (78.3%) underwent LVAD implantation as a bridge-to-transplant; 76 (27.4%) of the 277 were readmitted within 30 days. The most common reason for readmission was volume overload (23.6%), followed by gastrointestinal bleeding (15.8%). Male gender, previous smoking, a higher baseline creatinine level, higher Model for End Stage Liver Disease Excluding INR (MELD-XI) score, and postoperative gastrointestinal bleeding or stroke were each associated with 30 day readmission. In our final multivariate model, increased mortality was also associated with 30 day readmission (hazard ratio, 1.60; 95% confidence interval, 1.1-2.5). Among the 217...Continue Reading

References

May 16, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Jan-Willem LankhaarAnton Vonk-Noordegraaf
Mar 20, 2008·European Heart Journal·Jan-Willem LankhaarAnton Vonk-Noordegraaf
Nov 19, 2009·The New England Journal of Medicine·Mark S SlaughterUNKNOWN HeartMate II Investigators
May 1, 2012·The Annals of Thoracic Surgery·Ashim AggarwalGeetha Bhat
Dec 12, 2012·Journal of the American College of Cardiology·Tal HasinSudhir S Kushwaha
Mar 14, 2013·The Annals of Thoracic Surgery·Stephen J ForestDaniel J Goldstein
Jan 15, 2014·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Jennifer A CowgerFrancis D Pagani
Feb 4, 2014·Journal of the American College of Cardiology·Prateeti KhazanieAdrian F Hernandez
Jul 19, 2014·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Athanasios TsiourisJeffrey A Morgan
Nov 2, 2015·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·James K KirklinJames B Young
Dec 15, 2015·The American Journal of Cardiology·Parijat Saurav JoyLinda Marie Cadaret
Dec 19, 2015·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·James K KirklinLynne W Stevenson
Nov 21, 2016·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Simon MaltaisUNKNOWN PREVENT Study Investigators

❮ Previous
Next ❯

Citations

Apr 28, 2020·Journal of Cardiac Surgery·Brian AyersIgor Gosev
Aug 28, 2019·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·Valentina KutyifaJeffrey D Alexis
Oct 20, 2019·Interactive Cardiovascular and Thoracic Surgery·Ander Dorken GallastegiMustafa Özbaran
May 29, 2021·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·Saadia SheraziJeffrey D Alexis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Artificial Heart & Ventricular Assist Devices

Total artificial hearts (TAH) and ventricular assist devices (VADs) provide cardiac support for patients with end-stage heart disease and have significantly improved the survival of these patients. Discover the latest research on Artificial Heart and Ventricular Assist Devices here.